Bantilan KS, Kay NE, Parikh SA, Rabe KG, et al. Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selection. Leuk Lymphoma 2022 Dec 12:1-12. doi: 10.1080/10428194.2022.2148218.
PMID: 36503412